Results 151 to 160 of about 30,645 (194)

Development and internal validation of a CatBoost-SHAP-guided nomogram for significant liver fibrosis in children with chronic hepatitis B. [PDF]

open access: yesFront Med (Lausanne)
Zhang Y   +11 more
europepmc   +1 more source

KASL clinical practice guidelines for management of chronic hepatitis B Endorsed by the East Asia Liver Alliance (EALA). [PDF]

open access: yesClin Mol Hepatol
Choi WM   +19 more
europepmc   +1 more source

HBeAg Seroconversion as an Important End Point in the Treatment of Chronic Hepatitis B [PDF]

open access: yesHepatology International, 2009
During the natural history of chronic hepatitis B virus (HBV) infection, the loss of serum hepatitis B e antigen (HBeAg) and the development of anti-HBe antibodies (HBeAg seroconversion) mark a transition from the immune-active phase of disease to the inactive carrier state.
Yun-Fan Liaw
exaly   +3 more sources
Some of the next articles are maybe not open access.

Related searches:

Patients With Interferon-Induced HBeAg Seroconversion Have a Higher Risk of HBV Reactivation and HBeAg Seroreversion

Hepatology International, 2014
It remains unclear whether chronic hepatitis B patients who undergo interferon (IFN)-induced hepatitis B e antigen (HBeAg) seroconversion have a higher risk of hepatitis B virus (HBV) reactivation and HBeAg seroreversion than those with spontaneous HBeAg seroconversion.A total of 80 and 251 non-cirrhotic patients with interferon-induced and spontaneous
Jing-Houng Wang   +2 more
exaly   +3 more sources

Current Treatments for Patients With HBeAg-Positive Chronic Hepatitis B Virus Infection: A Comparison Focusing on HBeAg Seroconversion

Liver International, 2010
HBeAg seroconversion, in association with undetectable levels of hepatitis B virus DNA as determined by polymerase chain reaction, is an important goal in the treatment of patients with HBeAg-positive chronic hepatitis B (CHB). Achievement of sustained HBeAg seroconversion at an early age (
George Lau
exaly   +3 more sources

Long-Term Effect of Maternal HBeAg on Delayed HBeAg Seroconversion in Offspring With Chronic Hepatitis B Infection

Liver International, 2011
Abstract Background and aims: This cohort study investigated the long‐term effect of maternal hepatitis B virus (HBV) sero‐status on the spontaneous HBeAg seroconversion in offspring with chronic HBV infection. Methods: A total of 185 HBeAg‐positive chronic HBV‐infected children, with maternal HBV seromarkers checked, were ...
Jia-Feng Wu, Wan-Hsin Wen, Yen-Hsuan Ni
exaly   +3 more sources

Effect of Virological Response on Post-Treatment Durability of Lamivudine-Induced HBeAg Seroconversion

open access: yesJournal of Viral Hepatitis, 2002
Lamivudine-induced HBeAg seroconversion may not be durable in Korean patients with hepatitis B virus (HBV) infection. It is unknown whether virological response during lamivudine treatment affects the post-treatment outcome.
Sung-Won Cho, K B Hahm
exaly   +2 more sources

Relative Predictive Factors for Hepatocellular Carcinoma After HBeAg Seroconversion in HBV Infection

open access: yesWorld Journal of Gastroenterology, 2005
To determine the predictive factors for hepatocellular carcinoma (HCC) development in patients after spontaneous or therapeutic HBeAg seroconversion.In 48 patients who seroconverted to anti-HBe positive during follow-up, the background factors for HCC development were analyzed.HCC was developed in six patients during follow-up (average follow-up after ...
Kazumoto Murata   +2 more
exaly   +3 more sources

Home - About - Disclaimer - Privacy